Sildenafil NDC 59746-471

NDC codes

FDA NDC Directory

Product NDC (as listed)59746-471Labeler and product segments. Claims need a package NDC.

Product NDC at billing width59746-0471Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
59746-471-05	59746047105	500 TABLET, FILM COATED in 1 BOTTLE (59746-471-05)Marketed from Aug 26, 2024
59746-471-10	59746047110	1000 TABLET, FILM COATED in 1 BOTTLE (59746-471-10)Marketed from Aug 26, 2024
59746-471-90	59746047190	90 TABLET, FILM COATED in 1 BOTTLE (59746-471-90)Marketed from Aug 26, 2024

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Sildenafil
Generic name (nonproprietary): sildenafil
Active ingredients: Sildenafil citrate — 20 mg/1
Dosage form: Tablet, Film coated
Route: Oral
Labeler: Jubilant Cadista Pharmaceuticals Inc.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 202954
Marketing start: Aug 26, 2024
Listing expires: Dec 31, 2027
Other FDA classes: Phosphodiesterase 5 Inhibitors (Mechanism)
Identifiers: Product ID 59746-471_9a1dd479-ab39-4e0e-859b-33c7d7dbbf26SPL ID 9a1dd479-ab39-4e0e-859b-33c7d7dbbf26SPL set ID 7d13bf00-8daf-3087-a0b8-abb1fc572467RxCUI 577033UNII BW9B0ZE037UPC 0359746471057, 0359746471903, 0359746471101
Pharmacologic class: Phosphodiesterase 5 Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N459746047105 followed by a unit qualifier and the quantity

Package 59746-0471-05. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Mar 19, 2026.

Indications (excerpt from the label)

Adults Sildenafil tablets are indicated for the treatment of pulmonary arterial hypertension (PAH) (World Health Organization [WHO] Group I) in adults to improve exercise ability and delay clinical worsening [see Clinical Studies (14) ] . Pediatric use information is approved for Viatris Specialty LLC’s, REVATIO (sildenafil) tablets. However, due to Viatris Specialty LLC’s marketing exclusivity rights, this drug product is not labeled with that information. Adults Sildenafil tablets are phosphodiesterase-5 (PDE-5) inhibitor indicated for the treatment of pulmonary arterial hypertension (PAH) (World Health Organization [WHO] Group I) in adults to improve exercise ability and delay clinical wo…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 202954

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 202954
Product	Strength	Form · route	Labeler	Product NDC
Sildenafil	Sildenafil citrate 20 mg/1	Tablet, Film coatedOral	Golden State Medical Supply, Inc.	51407-987